mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.4 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.4 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.041 |
0.4 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.4 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |